Inplanta Innovations

What Inplanta Innovations does

Inplanta Innovations (株式会社インプランタイノベーションズ) is a Japan-based, privately held venture that originated from RIKEN — Japan's largest and most prominent comprehensive research institution — and provides plant development technologies and infrastructure. The firm is headquartered in Yokohama-shi, Japan, was founded in 2003, and operates with a small team of 11-50 employees. Its core offering centers on supporting plant-related research and development activities, suggesting a focus on tools, protocols, biological materials, or technical services relevant to plant science and biotechnology applications.

The business model is not disclosed in the available data. No pricing model, revenue mechanism, customer segment, or go-to-market approach is documented; no customer logos, partnerships, funding rounds, or product catalog are available. The company's operating status is confirmed active through its accessible website (inplanta.jp), but the homepage content provides only a title with no substantive detail on specific technologies, service tiers, or commercial offerings. Leadership consists of Takane Kenichi in the role of President and CEO.

The investment-relevant takeaway is that Inplanta Innovations is a small, long-lived RIKEN spinout in the plant biotechnology infrastructure space with extremely limited public disclosure. The absence of funding history, product detail, customer references, or financial metrics represents a substantial diligence gap. Any thesis on the company would require direct outreach to obtain core information on technology stack, revenue model, customer base, and competitive positioning.

Name

Inplanta Innovations

Legal name

株式会社インプランタイノベーションズ

Website

https://inplanta.jp

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Inplanta Innovations is a Japan-based, RIKEN-originated private venture founded in 2003 that provides plant development technologies and infrastructure. Operating from Yokohama with 11-50 employees, the firm serves the plant biotechnology domain.

Ownership category

akta.pro rank

Product category

Plant Biotechnology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Agricultural Services (700)

akta.pro primary industry

Biotechnology & Gene-Edited Trait Development (AFAGAIAG)

akta.pro secondary industries

Gene Editing Trait Development (CRISPR/TALEN/ZFN) (AFABALAB), Transformation & Tissue Culture Platforms (Plant regeneration, delivery systems) (AFABALAH)

Keywords

• Plant biotechnology
• Plant development
• Agricultural technology
• Life sciences infrastructure
• RIKEN venture

Headquarters

HQ city

Yokohama-shi

HQ country

Japan

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations

Core offering

Inplanta Innovations is a RIKEN-originated venture that provides plant development technologies and the supporting infrastructure required to apply them. The company operates in the plant biotechnology space, focused on translating RIKEN-derived research into usable plant-related technologies and platforms.

Product overview

Inplanta Innovations (株式会社インプランタイノベーションズ) is a Japanese technology company. The provided source data contains only a homepage title with no substantive information about products, services, or offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Plant development technologies A set of plant development technologies derived from RIKEN research and offered commercially by Inplanta Innovations, targeted at organizations working in plant science and biotechnology.
• Plant development infrastructure Supporting infrastructure that enables customers to operationalize plant development technologies, offered alongside the company's RIKEN-derived technology portfolio.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Others

• RIKEN (research collaboration peer): Japan's flagship national research institute from which Inplanta originated. Relevant as the technology source and likely ongoing research partner that supplies IP and scientific pipeline to the venture.
• Arctus Therapeutics: Venture-backed plant-based protein/ingredient company applying biotechnology to crop improvement. Adjacent comparable as a venture using biotech tools to develop differentiated plant-derived commercial products.

Emerging players

• Eden Brew: Australian precision fermentation company that originated from CSIRO. Comparable as a research-institute-originated (similar to RIKEN lineage) venture commercializing biological innovation in agriculture-adjacent markets.
• Tropic Bioscience: UK-based agricultural biotechnology company applying gene editing to tropical crops such as bananas and coffee. Comparable as a venture-backed specialist in plant development using advanced biotech tools.

Direct peers

• Pairwise: US-based plant genetics company using CRISPR and other gene-editing tools to develop improved crop varieties. Comparable as a venture-backed specialist in plant development technologies and trait innovation.
• Inari Agriculture: US-based SEEDesign company using AI and multiplex gene editing to develop step-change seed products. Comparable in applying advanced biotechnology platforms to plant trait and seed development.
• Sanatech Seed: Japanese pioneer in gene-edited tomatoes (Sicilian Rouge High GABA) and a leading commercializer of CRISPR-based plant traits in Japan. Directly comparable to Inplanta as a Japan-based plant biotech venture leveraging the country's regulatory framework for gene-edited crops.

Broad incumbents

• Syngenta Group: Global agribusiness major with deep R&D in plant genetics, seed technology, and crop protection. Comparable as a large incumbent that both competes with and acquires/licenses from niche plant biotech firms.
• Bayer Crop Science: Global agribusiness leader with extensive plant biotech, seed, and trait development capabilities including gene editing. Represents the large incumbent against which niche plant biotech ventures compete for partnerships and licensing deals.
• Corteva Agriscience: Global pure-play agriculture company combining seed, crop protection, and digital tools with strong plant biotech pipelines. Sets the competitive benchmark for trait development infrastructure and scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inplanta Innovations